How Does Leed Selection Impact Vascular Ablation? Optimize Efficacy & Safety

Linear Endovenous Energy Density (LEED) directly influences whether a treated vein closes permanently or develops complications. Too little energy may fail to produce complete thermal injury and increase recanalization, while too much energy raises the risk of pain, bruising, induration, perforation, and skin burns. The correct LEED must therefore be selected in relation to vessel diameter, laser wavelength, fiber position, pullback technique, and the effectiveness of tumescent protection.

LEED is a treatment-planning target, not a universal fixed dose. It should be individualized using ultrasound findings and the laser system’s validated protocol: sufficient energy must reach the vein wall for durable occlusion, but unnecessary energy should be avoided because thermal injury extends beyond the target.

Why LEED Matters During Vascular Ablation

LEED determines thermal injury to the vein wall

LEED is the energy delivered per unit length of treated vein, typically expressed in joules per centimeter (J/cm). It determines whether the intima and underlying vein wall receive enough heat to contract, thrombose, and undergo lasting fibrotic occlusion.

Insufficient thermal exposure can leave viable areas of the wall untreated. These segments may remain open immediately or later undergo recanalization, reducing clinical efficacy.

Vessel diameter changes the energy requirement

A larger vessel generally requires more carefully delivered energy because the fiber is farther from portions of the wall and blood may absorb part of the emitted light before it reaches the target.

The primary reference gives the following illustrative diameter-based targets:

50 J/cm for vessels approximately 2–4.5 mm
70 J/cm for vessels approximately 4.5–7 mm
90 J/cm for vessels approximately 7–10 mm

These values should not be treated as universal prescriptions. Vessel geometry, blood volume, wavelength, fiber type, delivery speed, and compression can substantially change the effective thermal dose.

LEED is not the same as optical fluence

LEED is expressed as J/cm, because it describes energy delivered along the length of a vessel. Fluence is generally expressed as J/cm², referring to energy per unit surface area.

Confusing these measures can lead to incorrect dosing. In endovenous ablation, the clinician should use the parameter specified by the system and treatment protocol rather than transfer fluence values from unrelated applications such as dermatology or hair removal.

How Energy Selection Affects Clinical Efficacy

Too little energy increases treatment failure

LEED below approximately 50–60 J/cm, or an otherwise inadequate dose for the vessel size, may produce incomplete injury to the vein wall. The risk is especially relevant in larger veins, where intraluminal blood can absorb energy and reduce wall exposure.

The clinical consequence may be incomplete closure, persistent flow, or later reopening. Increasing energy indiscriminately is not the solution; the delivery conditions must also be optimized.

Adequate energy supports durable occlusion

A properly selected LEED creates sufficient photothermal injury to cause collagen contraction, endothelial destruction, and subsequent fibrotic remodeling. Durable closure depends on achieving this effect along the entire treated segment.

Uniform pullback, appropriate fiber-wall positioning, vein compression, and adequate tumescent infiltration help ensure that the selected LEED is delivered effectively rather than concentrated in isolated areas.

Wavelength changes how energy reaches the wall

Hemoglobin-absorbing wavelengths, including commonly used wavelengths around 810, 940, and 980 nm, may transfer substantial energy through blood. This can increase local heating, particularly when blood remains in the vessel.

Water-selective wavelengths, such as 1320 nm, can target water in the vessel wall more directly. The relative risk profile depends on the complete system and protocol, but wavelength selection is an important reason why the same LEED should not automatically be applied across different platforms.

How LEED Selection Affects Safety

Excessive energy increases collateral thermal injury

The reference identifies LEED above approximately 100 J/cm as a level associated with a marked increase in adverse effects. Reported complications include:

Superficial cutaneous burns
Palpable induration
Vein-wall perforation
Increased post-procedural pain
Bruising and local tissue inflammation

The exact threshold is not absolute. A nominal LEED can produce different tissue effects depending on wavelength, treatment speed, vein depth, tumescent distribution, and whether the vein is adequately emptied and compressed.

Tumescent anesthesia provides thermal protection

Perivascular tumescent fluid acts as both a local anesthetic and a heat sink. It separates the treated vein from the skin and adjacent structures, reduces the temperature rise in surrounding tissue, and helps compress the vein around the fiber.

Tumescent fluid does not make excessive energy safe. It is a protective measure that must be combined with appropriate LEED, ultrasound guidance, and continuous awareness of fiber position.

Energy concentration is as important as total energy

Even an acceptable average LEED can cause injury if energy is deposited unevenly. Stopping the fiber, pulling back too slowly, or delivering repeated pulses to one location can create a focal hot spot.

Consistent fiber movement and adherence to the system’s validated power, pulse-duration, and pullback settings are therefore essential. The practical goal is not merely to reach a numerical LEED, but to distribute thermal exposure predictably along the vessel.

A Practical Selection Framework

Map the vessel before treatment

Pre-procedure ultrasound should document:

Vessel diameter
Depth from the skin
Anatomic course and tributaries
Tortuosity
Relationship to nerves and other vulnerable structures
Segments requiring different treatment settings

This information establishes whether a single LEED target is appropriate or whether the treatment should be adjusted by segment.

Match the target to the vessel and system

A diameter-based starting framework may use approximately 50, 70, or 90 J/cm for progressively larger vessel categories, as outlined above. The selected value must then be reconciled with the laser wavelength, fiber design, operating mode, and manufacturer or institutional protocol.

A larger diameter may justify a higher target, but simply increasing LEED can also increase collateral damage. Vein emptying, compression, and delivery consistency may improve wall contact without requiring an excessive energy increase.

Monitor the delivery process

During ablation, clinicians should confirm that:

The fiber tip remains in the intended location.
The vein is adequately compressed around the fiber.
Tumescent fluid surrounds the treated segment.
Pullback is continuous and controlled.
Energy is not being concentrated near the skin or a vulnerable structure.
The patient’s symptoms and tissue response remain within expected limits.

Ultrasound guidance supports both accurate targeting and safer management of variable anatomy.

Understanding the Trade-offs

More energy is not automatically more effective

Increasing LEED can improve closure when the initial dose is inadequate, but beyond the required thermal threshold it mainly increases tissue injury. The relationship is therefore not “more energy equals better treatment”; it is adequate energy with controlled distribution equals better treatment.

Fixed tables have limited portability

The 50/70/90 J/cm framework is useful as an educational starting point, but it should not be transferred unchanged between laser systems or wavelengths. Different systems may produce different tissue effects at the same nominal LEED.

Clinical protocols should therefore be validated for the specific device, fiber, wavelength, and technique. Patient anatomy and treatment response remain more important than rigid adherence to a generic table.

Large veins present competing risks

Larger veins may need more energy for complete wall injury, yet they also contain more blood and may be harder to collapse uniformly. This creates a dual risk: inadequate wall treatment in some regions and excessive focal heating in others.

The appropriate response is careful planning and controlled delivery, not automatic escalation of power or LEED.

Safety must include follow-up

Immediate technical success does not guarantee durable closure. Follow-up assessment, commonly with ultrasound according to the treating service’s protocol, helps identify persistent flow, recanalization, thrombotic complications, or other unexpected findings.

How to Apply This to Your Project

Use LEED as one part of a complete treatment-control strategy rather than as an isolated number.

If your primary focus is durable vein occlusion: Start with ultrasound-based vessel sizing, select a validated diameter-appropriate LEED, and ensure uniform fiber-wall contact and controlled pullback.
If your primary focus is minimizing complications: Avoid excessive or locally concentrated energy, use adequate perivascular tumescent protection, and monitor fiber position and tissue response continuously.
If your primary focus is standardizing a medical diode laser system: Validate LEED settings for the specific wavelength, fiber, power, pulse mode, and vessel characteristics instead of importing values from another platform.

The safest and most effective LEED is the lowest reliably delivered energy that produces complete, uniform vein-wall injury under the specific clinical conditions.

Summary Table:

LEED Level	Typical Vessel Size	Potential Outcome	Safety Considerations
<50 J/cm	-	Incomplete closure, recanalization	Lower thermal injury risk
50 J/cm	2-4.5 mm	Durable occlusion	Manageable adverse effects
70 J/cm	4.5-7 mm	Durable occlusion	Increased pain/bruising potential
90 J/cm	7-10 mm	Durable occlusion	Higher risk of collateral damage
>100 J/cm	-	Severe complications (burns, perforation)	High thermal injury risk

Optimize your vascular ablation outcomes with BELIS' advanced medical diode laser systems. Our professional-grade equipment is designed for precise LEED control, ensuring both efficacy and safety for your clinic. Contact us today to learn how our technology can enhance your practice.